This basic science study demonstrates that HDL apoprotein binds with phospholipids to form a complex capable of activating lipoprotein lipase, supporting the concept that HDL consists of apoprotein subunits held by lipid bridges.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open whether reconstituted complexes regulate lipoprotein lipase in humans.
The apoprotein separated from human serum lipoproteins of density 1.063 to 1.21 (HDL) by extraction with ethanol-ethyl ether (3:2) at -10° was shown to recombine in definite stoichiometric ratios either with the whole phospholipids of HDL or with the lecithin, phosphatidylethanolamine, and sphingomyelin fractions separated from the same lipoproteins. For the reaction, aqueous dispersions of phospholipids were obtained by sonic oscillation. HDL apoprotein maintained its binding property for phospholipids after acetylation, succinylation, reduction and alkylation, and treatment with neuraminidase, as well as in the presence of urea. The reconstituted protein-phospholipid complex acted as a substrate activator for the enzyme lipoprotein lipase obtained from chicken adipose tissue. This activity, previously reported for whole HDL, was not observed when either HDL apoprotein or phospholipids were used alone. The results are considered compatible with the concept that HDL is made of apoprotein subunits held by lipid bridges.
No takes yet. Share an insight, caveat, or question.
Angelo M. Scanu (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: